Neovascular glaucoma represents a challenging ophthalmic emergency where abnormal blood vessel growth on the iris and angle structures leads to a rapid and severe increase in intraocular pressure. The accurate identification and classification of this condition are critical for initiating timely intervention and preserving remaining vision. For medical coders, clinicians, and billing specialists, understanding the specific ICD-10 code for neovascular glaucoma is essential for precise documentation and reimbursement, reflecting the underlying etiology rather than just the glaucoma itself.
Understanding the Pathophysiology and Classification
Unlike primary open-angle or angle-closure glaucoma, neovascular glaucoma is a secondary form arising from an underlying ischemic drive. Conditions such as diabetic retinopathy, central retinal vein occlusion, or sickle cell disease trigger the release of vascular endothelial growth factor (VEGF), prompting the growth of fragile, new vessels on the iris (rubeosis iridis). These vessels can physically obstruct the eye's drainage angle, causing a sudden and often painful spike in intraocular pressure that does not respond well to standard medications.
The Primary ICD-10 Code Assignment
The cornerstone of coding neovascular glaucoma lies in sequencing two codes to capture both the glaucoma and its root cause. The primary code for the glaucoma itself is H40.2, which falls under the category for secondary glaucoma. This code specifies the condition as neovascular, indicating the proliferative nature of the disease process affecting the eye's outflow system.
Code H40.2: Secondary Glaucoma, Neovascular
H40.2 is the specific ICD-10 code for neovascular glaucoma, classifying it as a form of secondary open-angle glaucoma. This code should be used to indicate the glaucoma component of the disease. It is important to note that this code does not specify the laterality (right eye, left eye, or bilateral); a fifth character extension is required to denote the specific eye affected if the documentation provides that detail.
Capturing the Underlying Etiology
Because neovascular glaucoma is a consequence of another systemic or ocular condition, a second code is mandatory to identify the underlying disorder. This is where the coding specificity becomes crucial. The coder must review the medical documentation thoroughly to determine the exact cause, as this directly impacts the assigned code and the clinical management strategy.
Common Etiological Codes
E11.42: Type 2 diabetes mellitus with diabetic retinopathy.
I36.2: Obstruction and stenosis of retinal veins, a common trigger for retinal ischemia.
H35.3: Retinal vasculopathy, encompassing various vascular retinal disorders.
H35.34: Ischemic optic neuropathy, another potential cause of retinal neovascularization.
Code Sequencing and Practical Application
When documenting a case, the standard practice is to list the neovascular glaucoma code (H40.2) first, followed by the code for the underlying condition. This sequence reflects the medical logic: an ischemic event or disease process leads to neovascularization, which subsequently causes the secondary glaucoma. For example, a patient with diabetic retinopathy who develops neovascular glaucoma would be coded as H40.2, E11.42.
Laterality and Specificity in Coding
To ensure complete and billable claims, the fifth character in the H40.2 code must specify the affected eye. The documentation should clearly state whether the condition is unilateral (affecting one eye) or bilateral (affecting both eyes). If the medical record specifies a laterality, the coder must use the appropriate extension: ".0" for bilateral, ".1" for right eye, or ".2" for left eye. This level of detail is required for accurate reimbursement and epidemiological tracking.
